Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.49 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 2/20 | 0.46 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.45 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.44 |
| ▸ | CPT2 | P23786 | 1/20 | 0.44 |
| ▸ | CPT1A | P50416 | 1/20 | 0.44 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3970543 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL67008 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL19281111 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL8660979 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL3657071 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL94325 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL5196744 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL90356 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL319255 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL74160 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| CN-121203552-B | Corrosion-resistant through silicon via copper film chemical mechanical polishing solution and application thereof | Xinyue Microelectronic Materials (Jiaxing) Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260108440-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2026-04-23 | — | — | US | claimed |
| US-20260060909-A1 | HAIR CARE COMPOSITION COMPRISING TERTIARY AMIDOAMINES SURFACTANT (TAS), SALICYLIC ACID, FREE OF FATTY ALCOHOL AND PH= 6.5 | L'OREAL (FR) | 2026-03-05 | — | — | US | claimed |
| US-20260047988-A1 | HAIR COSMETIC COMPOSITIONS AND METHOD OF TREATING HAIR | L'OREAL (FR) | 2026-02-19 | — | — | US | claimed |
| EP-4633589-A1 | HAIR TREATMENT COMPOSITIONS THAT IMPART SHINE AND LUSTER | L'OREAL (FR) | 2025-10-22 | — | — | EP | claimed |
| US-12377039-B2 | Cleansing compositions | L'OREAL (FR) | 2025-08-05 | — | — | US | claimed |
| WO-2025129302-A1 | COMPOSITION FOR TREATING KERATIN FIBERS AND METHOD FOR TREATING KERATIN FIBERS | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| WO-2025129288-A1 | COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| WO-2025129473-A1 | COMPOSITION AND PROCESS FOR DYEING KERATIN FIBERS | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| WO-2003028777-A1 | INHIBITION OF EXOPROTEINS USING ISOPRENOIDS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2003-04-10 | — | — | WO | claimed |
| EP-1103276-A1 | Inhibition of exoprotein in absorbent article | Kimberly-Clark Worldwide, Inc. (US) | 2001-05-30 | — | — | EP | claimed |
| EP-0617953-B1 | Clear conditioning composition | CURTIS HELENE IND INC (US) | 1998-11-18 | — | — | EP | claimed |
| EP-0846005-A2 | INHIBITION OF EXOPROTEIN IN ABSORBENT ARTICLE | Kimberly-Clark Worldwide, Inc. (US) | 1998-06-10 | — | — | EP | claimed |
| US-5685872-A | GRAM POSITIVE BACTERIA, TAMPONS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1997-11-11 | — | — | US | claimed |
| WO-1996040300-A2 | INHIBITION OF EXOPROTEIN IN ABSORBENT ARTICLE | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| US-5556615-A | Clear conditioning composition | HELENE CURTIS, INC. (US) | 1996-09-17 | — | — | US | claimed |
| EP-0617953-A1 | Clear conditioning composition | Helene Curtis Industries, Inc. (US) | 1994-10-05 | — | — | EP | claimed |
| US-5328685-A | Amidoamine salt, silicone compound containing quaternary ammonium group | HELENE CURTIS, INC. (US) | 1994-07-12 | — | — | US | claimed |
| EP-0275719-A2 | Ultraviolet absorbing compounds and formulations including same | Richardson-Vicks, Inc. (US) | 1988-07-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060909-A1 | HAIR CARE COMPOSITION COMPRISING TERTIARY AMIDOAMINES SURFACTANT (TAS), SALICYLIC ACID, FREE OF FATTY ALCOHOL AND PH= 6.5 | KRT18, ADH1A, ADH1C | FAAH 9/4885MEN1 3620/4885KMT2A 2104/4885 |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | FAAH 364/4885MEN1 2466/4885KMT2A 2037/4885 |
| US-20260047988-A1 | HAIR COSMETIC COMPOSITIONS AND METHOD OF TREATING HAIR | HCAR1, CUTA, HCAR3 | FAAH 276/4885MEN1 4338/4885KMT2A 3164/4885 |
| US-20260108440-A1 | Personal Care Compositions | PBDC1, PIEZO1, TRPC7 | FAAH 2667/4885MEN1 3357/4885KMT2A 2504/4885 |
| US-12377039-B2 | Cleansing compositions | SMURF1, SMURF2, SGMS2 | FAAH 327/4885MEN1 2591/4885KMT2A 3030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.